Literature DB >> 22376149

The role of obesity in the development of polycystic ovary syndrome.

Alicia Beatriz Motta1.   

Abstract

Polycystic Ovary Syndrome (PCOS) is one of the common endocrine diseases that affects women in their reproductive age. PCOS has diverse clinical implications that include reproductive (infertility, hyperandrogenism, hirsutism), metabolic (insulin resistance, impaired glucose tolerance, type 2 diabetes mellitus, cardiovascular diseases) and psychological features (increased anxiety, depression and worsened quality of life). The exact patho-physiology of PCOS is complex and remains largely unclear. The prevalence of PCOS is estimated at 4-18%, depending on diverse factors discussed ahead. The phenotype varies widely depending on life stage, genotype, ethnicity and environmental factors including lifestyle and body weight. During the last decades, obesity and excess weight are major chronic diseases all around the word. Obesity increases some features of PCOS such as hyperandrogenism, hirsutism, infertility and pregnancy complications. Both obesity and insulin resistance increase diabetes mellitus type 2 and cardiovascular diseases. Moreover, obesity impairs insulin resistance and exacerbates reproductive and metabolic features of PCOS. It is well known that obesity is associated with anovulation, pregnancy loss and late pregnancy complications (pre-eclampsia, gestational diabetes). Obesity in PCOS is also linked to failure or delayed response to the various treatments including clomiphene citrate, gonadotropins and laparoscopic ovarian diathermy. It has been reported that, after losing as little as 5 % of initial body weight obese women with PCOS improved spontaneous ovulation rates and spontaneous pregnancy. Therefore, the weight loss prior to conception improves live birth rate in obese women with or without PCOS. The treatment of obesity may include lifestyle therapy (diet and exercise), pharmacological treatment and bariatric surgery. In summary, weight loss is considered the first-line therapy in obese women with PCOS. In the present review, the consequence and treatment of obesity in women with PCOS are discussed.

Entities:  

Mesh:

Year:  2012        PMID: 22376149     DOI: 10.2174/13816128112092482

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  18 in total

1.  Prevalence of polycystic ovary syndrome in adolescents.

Authors:  Shawna B Christensen; Mary Helen Black; Ning Smith; Mayra M Martinez; Steve J Jacobsen; Amy H Porter; Corinna Koebnick
Journal:  Fertil Steril       Date:  2013-06-05       Impact factor: 7.329

2.  Effect of orlistat on weight loss, hormonal and metabolic profiles in women with polycystic ovarian syndrome: a randomized double-blind placebo-controlled trial.

Authors:  Ashraf Moini; Mahia Kanani; Ladan Kashani; Reihaneh Hosseini; Ladan Hosseini
Journal:  Endocrine       Date:  2014-10-08       Impact factor: 3.633

3.  Indications for Surgery for Obesity and Weight-Related Diseases: Position Statements from the International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO).

Authors:  Maurizio De Luca; Luigi Angrisani; Jacques Himpens; Luca Busetto; Nicola Scopinaro; Rudolf Weiner; Alberto Sartori; Christine Stier; Muffazal Lakdawala; Aparna G Bhasker; Henry Buchwald; John Dixon; Sonja Chiappetta; Hans-Christian Kolberg; Gema Frühbeck; David B Sarwer; Michel Suter; Emanuele Soricelli; Mattias Blüher; Ramon Vilallonga; Arya Sharma; Scott Shikora
Journal:  Obes Surg       Date:  2016-08       Impact factor: 4.129

4.  Plasminogen activator inhibitor-1 -675 4G/5G polymorphism and polycystic ovary syndrome risk: a meta analysis.

Authors:  Ying Liu; Mei-Guo Sun; Rong Jiang; Rui Ding; Zhen Che; Yan-Yan Chen; Ci-Jiang Yao; Xiao-Xia Zhu; Ji-Yu Cao
Journal:  J Assist Reprod Genet       Date:  2014-01-17       Impact factor: 3.412

Review 5.  Endocrine changes (beyond diabetes) after bariatric surgery in adult life.

Authors:  S Savastano; C Di Somma; R Pivonello; G Tarantino; F Orio; V Nedi; A Colao
Journal:  J Endocrinol Invest       Date:  2013-02-27       Impact factor: 4.256

Review 6.  Obesity Disease and Surgery.

Authors:  Abdulrahman Saleh Al-Mulhim; Hessah Abdulaziz Al-Hussaini; Bashaeer Abdullah Al-Jalal; Rehab Omar Al-Moagal; Sara Abdullah Al-Najjar
Journal:  Int J Chronic Dis       Date:  2014-04-28

7.  Plastics derived endocrine disruptors (BPA, DEHP and DBP) induce epigenetic transgenerational inheritance of obesity, reproductive disease and sperm epimutations.

Authors:  Mohan Manikkam; Rebecca Tracey; Carlos Guerrero-Bosagna; Michael K Skinner
Journal:  PLoS One       Date:  2013-01-24       Impact factor: 3.240

8.  Ancestral dichlorodiphenyltrichloroethane (DDT) exposure promotes epigenetic transgenerational inheritance of obesity.

Authors:  Michael K Skinner; Mohan Manikkam; Rebecca Tracey; Carlos Guerrero-Bosagna; Muksitul Haque; Eric E Nilsson
Journal:  BMC Med       Date:  2013-10-23       Impact factor: 8.775

9.  The Relationship between Intake of Dairy Products and Polycystic Ovary Syndrome in Women Who Referred to Isfahan University of Medical Science Clinics in 2013.

Authors:  Golnaz Rajaeieh; Mohamadreza Marasi; Zahra Shahshahan; Fatemmeh Hassanbeigi; Seied Morteza Safavi
Journal:  Int J Prev Med       Date:  2014-06

10.  Association of obesity-mediated insulin resistance and hypothalamic volumes: possible sex differences.

Authors:  Jenny Ha; Jessica I Cohen; Aziz Tirsi; Antonio Convit
Journal:  Dis Markers       Date:  2013       Impact factor: 3.434

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.